Saudi Arabia Blood Glucose Device Market Size & Trends 2025-2033

The Saudi Arabia Blood Glucose Device Market is projected to grow at US$ 143.96 Million in 2024 to US$ 259.8 Million in 2033 at a CAGR of 6.78% over the forecast period 2025-2033. The market is fueled by the increasing incidence of diabetes, increasing awareness about health, and government initiatives for early diagnosis and self-blood glucose monitoring. Recent advances in continuous glucose monitoring (CGM) systems and easy-to-use glucometers are enhancing patient compliance and results.

Saudi Arabia Blood Glucose Device Market Overview

A blood glucose meter is a medical device that quantifies the level of glucose (sugar) in the bloodstream. They are an essential tool for people with diabetes to help them control and manage the condition effectively. Most commonly, they are glucometers, continuous glucose monitors (CGM), or flash glucose monitors, which provide real-time or interval sugar levels. Proper glucose monitoring averts complications like hypoglycemia, hyperglycemia, and chronic organ damage.

In Saudi Arabia, blood glucose meters have become very popular as a result of the high and increasing rate of diabetes, which is one of the topmost public health problems in the country.

Lifestyle issues such as lack of physical activity, high-calorie diets, and rising obesity levels have fueled this phenomenon. The government has initiated various awareness campaigns and public health programs promoting early detection and self-management. Moreover, easy access to blood glucose monitors through pharmacies and online stores, insurance coverage, and technological advances has exposed them to both urban and rural communities throughout the Kingdom.

Growth Drivers in the Saudi Arabia Blood Glucose Device Market

Increased Type 2 Diabetes Prevalence

Saudi Arabia has a very high rate of diabetes prevalence in the world, and Type 2 diabetes is prevalent among most of the adult population. Inactive lifestyles, poor eating habits, and growing obesity levels are the key causes. With rising awareness, more people are opting for blood glucose meters for regular monitoring and early treatment. The government as well as the healthcare sector is also placing emphasis on self-care to prevent complications and healthcare expenses, thereby increasing demand further.

This burden of chronic disease is likely to fuel steady expansion in the blood glucose device market during the forecast period. Over one in ten individuals in Saudi Arabia had diabetes, and the disease's prevalence was set to nearly double by the year 2045, as stated in the IDF report. The report also stated that 4.27 million individuals in Saudi Arabia, a country with a population of approximately 34.8 million, suffer from diabetes, whereas an additional 1.86 million have the condition but are not diagnosed yet. The number is predicted to rise to 5.6 million in 2030 and continue to rise to 7.5 million in 2045.

Technological Advancements and User-Friendly Devices

The ready availability of modern blood glucose monitors, including Continuous Glucose Monitoring (CGM) systems and Bluetooth glucometers, is transforming the management of diabetes. They are providing better accuracy, real-time monitoring, and smartphone connectivity, enabling improved diabetes management. Simple-to-use interfaces, smaller sizes, and painless testing techniques enhance their appeal to younger and older people.

While global players make an entry into the Saudi market with state-of-the-art innovations, patients gain through enhanced choices that enhance compliance and enhance long-term results, fuelling adoption across age ranges. August 2023, Nemaura Medical received authorization by the Saudi Food and Drug Authority (SFDA) for its non-invasive glucose sensor wearable, sugarBEAT. Regarded as a Class IIb medicinal device with a CE mark, the device offers useful information using daylong glucose monitoring and review of daily glucose patterns.

Government Programs and Public Health Campaigns

Vision 2030 health sector reform is being heavily funded by the government of Saudi Arabia with a focus on disease prevention and early detection. Screening programs for diabetes, school and workplace awareness programs, and collaboration with healthcare providers are enhancing diagnosis rates and encouraging frequent glucose monitoring.

Subsidies for the necessary medical equipment and insurance coverage for diabetes care have further enhanced access to blood glucose equipment. Monitoring equipment is also being more commonly installed in hospitals and primary care facilities.

These forward-looking initiatives by the public sector are fast-tracking market penetration and promoting the adoption of blood glucose monitoring devices across the board. For example, in 2024, the Saudi Ministry of Health collaborated with Ithnain to improve diabetes control, launching innovative coaching for more than 10,000 patients and keeping in line with Vision 2030 to develop healthcare solutions throughout the Kingdom. This program is consistent with Saudi national health policies for Vision 2030 and reflects Saudi Arabia's increasing interest in diabetes awareness and effective management.

Obstacles in the Saudi Arabia Blood Glucose Device Market

Excessive Cost of Sophisticated Devices

In spite of the benefits of CGMs and intelligent glucometers, their excessive cost is a deterrent for most consumers. High-tech blood glucose devices with digital capabilities or continuous monitoring features tend to have a higher cost, and not all health insurance plans provide full coverage. The premium pricing issue disproportionately targets low - and middle-income patients, making regular monitoring less accessible.

Therefore, many continue to use less efficient or older monitoring devices. Without increased affordability or wider insurance cover, widespread use of high-tech blood glucose devices is a major hurdle in the Kingdom.

Limited Compliance and Awareness in Rural Regions

Despite good healthcare facilities and awareness campaigns in urban areas such as Riyadh and Jeddah, rural and remote areas lack proper awareness and access to diabetes care. Poor compliance due to limited understanding of the necessity for frequent glucose monitoring and how to use the devices effectively contributes to this. Some patients also lack technical competence for newer machines.

These differences impact early diagnosis and continuation disease management. Widening outreach, education, and distribution to underserved communities is an essential barrier to achieving countrywide use of blood glucose monitoring technologies.

Saudi Arabia Blood Glucose Device Market for Test Strips

Test strips are a central part of blood glucose testing and represent a significant percentage of device-associated spending. They are used extensively in Saudi Arabia in combination with conventional glucometers as spot-checking tools for monitoring glucose levels.

They are convenient to use and low in cost, explaining their popularity among older patients and patients suffering from Type 2 diabetes. Yet over time, recurring expenses can mount, posing affordability issues for extended users. The industry is sustained by international and domestic suppliers providing different types of strips compatible with diverse meters. Steady demand for test strips underpins the overall expansion of the glucose monitoring ecosystem.

Saudi Arabia Type 2 Diabetes Blood Glucose Device Market

Type 2 diabetes prevails over the burden of diabetes in Saudi Arabia, which makes it a driving force behind the demand for blood glucose monitoring devices. Such patients need ongoing glucose monitoring to control blood sugar levels, prevent complications, and maximize the administration of drugs.

Ease-of-use products, characterized by large displays and low blood needs, are highly sought after among elderly Type 2 diabetics. Healthcare professionals increasingly advise home monitoring to minimize hospital visits. With improving chronic disease management programs in public and private clinics, demand for blood glucose devices in Type 2 diabetes patients is likely to increase substantially.

Saudi Arabia Blood Glucose Device Hospital Pharmacies Market

Hospital pharmacies in Saudi Arabia serve as key points of distribution for blood glucose monitoring devices, especially for new patients who have been diagnosed. Such settings enable direct patient education and device training in the presence of medical practitioners. Hospitals tend to have a selection of glucometers and test strips in inventory, including pediatric and geriatric equipment.

In public hospitals, devices could be subsidized or given at no charge to eligible patients, ensuring equal access. With increasing hospital admissions for diabetes complications, hospital pharmacies are still central to introducing patients to monitoring technology and ensuring continued usage compliance.

Saudi Arabia Blood Glucose Device Retail Pharmacies Market

Retail pharmacies are the most convenient retail outlet for the sale of blood glucose devices and accessories such as test strips and lancets. Chains like Al Nahdi, White Pharmacy, and Al-Dawaa provide numerous brands and models at discounted rates or by way of loyalty programs in-store. Pharmacists are also responsible for educating customers on device use and choice.

Retail pharmacies' growing presence in smaller cities and rural areas is contributing to broadening market reach. Home delivery and online ordering services provided by these pharmacies also increase accessibility, which reinforces the ongoing expansion of this channel of distribution.

Dhahran Blood Glucose Device Market

Dhahran, one of Saudi Arabia's main cities in the Eastern Province, is famous for its affluent population and access to large healthcare institutions. The city enjoys a well-established medical infrastructure base and high levels of private healthcare penetration, and thus it has recorded high adoption rates of sophisticated blood glucose monitoring devices.

Demand is strongest among middle-aged and elderly population, consistent with nationwide diabetes trends. Hospitals, pharmacies, and specialty clinics in Dhahran tend to stock current technologies, including CGMs. Educational initiatives underwritten by firms and local health departments continue to raise awareness further, such that Dhahran is a fast-emerging center for diabetes management innovation.

Riyadh Blood Glucose Device Market

Being the capital and largest city, Riyadh is the biggest market for blood glucose devices in Saudi Arabia. The city has a very high density of hospitals, diabetes specialty centers, and diagnostic laboratories, so it is leading the early detection and glucose monitoring efforts.

Riyadh has Vision 2030 healthcare objectives of the government fully integrated into it, which has led to increased access to diagnostic tools. Urban consumers prefer smart glucose meters and app-connected devices more. Riyadh, being a population with high penetration of technology and a strong private healthcare industry, is an ideal market for expansion and innovation in the market for glucose monitoring.

Jeddah Blood Glucose Device Market

Jeddah, which is one of the prominent urban areas along the Red Sea coast, has experienced a steep increase in lifestyle disorders, such as Type 2 diabetes. The health infrastructure of the city facilitates broad access to blood glucose monitors among hospitals, clinics, and shops. With a local and expatriate mix of populations, the demand ranges from simple glucometers to sophisticated wearable sensors.

The availability of wellness programs and health campaigns has raised consumers' awareness levels and prompted early take-up. Jeddah's dynamic healthcare industry, combined with advances in digital health, makes it a focus growth area for blood glucose device distributors and manufacturers.

Market Segmentation

Product

• Test Strips
• Lancets
• Blood Glucose Meters

Application

• Type 1 Diabetes
• Type 2 Diabetes
• Gestational Diabetes

End User

• Hospital Pharmacies
• Retail Pharmacies
• Online Sales
• Diabetes Clinics & Centers

Top States

• Dhahran
• Riyadh
• Khobar
• Jeddah
• Dammam
• Others

Key Players Analysis (Overviews, Key Persons, Recent Developments, SWOT Analysis, Revenue Analysis)

• Abbott Laboratories
• Medtronic
• Dexcom Inc.
• B. Braun Melsungen AG
• DarioHealth Corp
• Sanofi
• Bionime Corporation
• Novo Nordisk